Formulation and Evaluation of Ethosomal Cream containing Resveratrol for the Treatment of Contact Dermatitis

  • Nidhika Kaundal Shiva Institute of B.Pharmacy, Bilaspur, Himachal Pradesh, India-174004
  • Pravin Kumar Laureate Institute of Pharmacy, Kangra, Himachal Pradesh, India- 177101


Objective: The aim of this study was to formulate and evaluate ethosomal cream containing resveratrol for the treatment of contact dermatitis.

Method: Resveratrol-loaded ethosome was prepared using cold method. The prepared ethosomes were assessed for entrapment efficiency (%), TEM analysis and sedimentation rate to determine the optimal formulation for loading into cream base. The selected formulation was further investigated for particle size distribution and zeta potential. A cream base was formulated using fusion and trituration method and selected for loading with the ethosomal suspension, meeting specification suitable for topical delivery.  Ethosomal cream formulations were evaluated for drug content, ex -vitro diffusion by using goat skin, skin retention, microbiological study and stability study. 

Result and Discussion: The formulation E3 was selected for loading in the optimized cream base (F4) to obtain a topical cream containing ethosomes of resveratrol. The release study reveals that release was controlled for the 24 hours. The drug release in buffer was less than 17% from all the formulations after 24 hours. The drug content of resveratrol in goat skin and cream remained in donor compartment indicates that the drug retention in skin was high in all the formulations, which is desirable for the topical formulations. The best possible release kinetics of the formulation loaded with resveratrol containing ethosomes was found to be zero order. The ‘n’ value from Peppas’s model indicated that the drug release was by Fickian diffusion. Stability study indicates that all the cream formulations were stable after a time period of one month.

Conclusion: The present study conclusively supported that ethosomal cream containing resveratrol to be an advantageous topical drug delivery system in treatment of ACD. However detail in- vivo study should be conducted in future to be justify the in- vitro study.

Keywords: Resveratrol, Ethosome, Cream, Contact dermatitis.

Keywords: Resveratrol, Ethosome, Cream, Contact dermatitis


Download data is not yet available.

Author Biographies

Nidhika Kaundal, Shiva Institute of B.Pharmacy, Bilaspur, Himachal Pradesh, India-174004

Shiva Institute of B.Pharmacy, Bilaspur, Himachal Pradesh, India-174004

Pravin Kumar, Laureate Institute of Pharmacy, Kangra, Himachal Pradesh, India- 177101

Laureate Institute of Pharmacy, Kangra, Himachal Pradesh, India- 177101


1. Shah K. Myths on chemical basis in the diaper area; Clinical Pediatrics. 2017; 56(5S): 135-155. PMid:28420253
2. Koppes S. A, et al. Current knowledge on biomarkers for contact dermatitis. John Wiley & sons. 2017; 1-16.
3. Mowad M .C, Anderson B, Scheinman P, Pooongkam S, Nedorost S, Brod B. Allergic contact dermatitis patient diagnosis and evaluation. American academy of Dermatology. 2016; 1029-1040. PMid:27185421
4. Leung DYM, Bogunweizch M, Howell MD, Nomura I, Hamid QA. New insights in atopic dermatitis. The Journal of Clinical Investigation. 2004; 105(5): 860-876. PMid:14991059 PMCid:PMC351324
5. Usatine PR, Riojas M, Diagnosis and management of contact dermatitis. American Family Physician. 2017; 82(3): 251-255.
6. Al-Otaibi S.T, Alqahtani H.A.M, Management of contact dermatitis. Journal of Dermatology & Dermatologic Surgery. 2015; 19: 86-91.
7. Brasch J, et al. Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG. Allergo J Int. 2014; 23: 126-38 PMid:26146602 PMCid:PMC4484750
8. Jung Y, Bjungju Kim B, Ryu H .M, Kim H; Chinese medicines reported to have effect on contact dermatitis In the last 20 years. Chin J Integr Med. 2016; 24(1): 1-8. PMid:28251475
9. Sun S, Zhang M, Yang Q, Shen Z, Chen J, Yu B, et al. Resveratrol suppresses lipoprotein-associated phospholipase A2 expression by reducing oxidative stress in macrophages and animal model. Molecular Nutrition & Food Research. 2017; 1-33. PMid:28608449
10. Amri A, Chaumeil JC, Safar S, Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations? Journal of Controlled Release. 2012; 158: 182-193. PMid:21978644
11. Wasik A, Antkiewicz-Michaluk L. The mechanism of neuroprotective action of natural compounds. Pharmacological Reports. 2017; 1-17. PMid:28623709
12. Caglayan SS, Karaman M, Cilaker MS, Isik S, Arikan AZ, Bagriyanik A, Uzuner N, Karaman O. Resveratrol ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium. Allergy and clinical Immunology. 2006; 4 e: 1889. PMid:27069818 PMCid:PMC4824908
13. Sahu T, Patel T, Sahu S, Gidwani B. Skin Cream as Topical Drug Delivery System: A Review. Journal of Pharmaceutical and Biological science. 2016; 4(5): 149-154.
14. Limsuwan T, Boonme P, etal. Ethosomes of phenylethyl resorcinol as vesicular delivery system for skin lightening application. International Journal of Biomedicine and Research. 2017; 1-12. PMid:28804723 PMCid:PMC5540262
15. Comont L, Cottart HC, Rhayem Y, Antoine NV, Djelidi R, Collin F, et al. Simple spectrophotometric assessment of trans-/ cis- resveratrol ratio in aqueous solution. Analytica chimica Acta. 2009; 63: 121-128. PMid:19154820
16. Nour V, Ion T, Muntean C. Ultraviolet Irradiation of Trans-Resveratrol and HPLC: Determination of Trans-Resveratrol and Cis-Resveratrol in Romanian Red Wines. Journal of Chromatographic Science. 2012; 50(10): 920-927. PMid:22689901
17. Robinson K, Mock C, Liang D. Pre-formulation studies of resveratrol. Drug Development and Industrial Pharmacy. 2014; 1-6. PMid:25224342 PMCid:PMC4427559
18. Jumaily F, Shafiq AZ, Al-bayati IR. Synthesis of New derivatives of resveratrol and to explore its potential health benefits. Chemical Science Transactions. 2013; 2(1): 1-8.
19. Touitou E, Alkabes M, Dayan N, Eliaz M. Ethosomes: the novel vesicular carriers for enhanced skin delivery. Pharmaceutical Research. 1997; 14: 305-306.
20. Touitou E, Dayan N, Bergelson L, et al. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. Journal of Control Release. 2000; 65: 403-18. PMid:10699298
21. Supraja R, Sailaja KA. Formulation of Mefenamic Acid Loaded Ethosomal Gel by Hot and Cold Methods. Nano Biomedicine and Engineering. 2017; 9(1): 27-35.
22. Abdulbaqi IM, Darwis Y, Khan NA, Assi RA, Khan AA. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. International Journal of Nanomedicine. 2016; 11: 2279-2304. PMid:27307730 PMCid:PMC4887071
23. Sarwa KK, Mazumder B, Rudrapal M, Verma VK. Potential of capsaicin-loaded transfersomes in arthritic rats. Drug Deliv. 2015; 22(5): 638-46. PMid:24471764
24. Surini S, Nastiti PD, Putri AR, Putri KSS. Formulation of Andrographollide Transfersomes gel for transdermal delivery: A preliminary study. Int J Appl Phar. 2020; 12(1): 187-91.
25. Mehta RM. Dispensing pharmacy. Vallabh Prakashan Pvt. Ltd. New Delhi; 2004.
26. Bureau of Indian Standard of Skin cream specification. 2nd edition. IS 6608; 2004.
27. Multimer, M. Spreadability determination by an apparatus, Journal of American Pharmacist Association. 1956; 45: 212-214.
28. Martin A, Bustamante P, Chun AHC. Physical Pharmacy, 4th Edn. B. I. Waverly Pvt. Ltd; 1999.
29. Higuchi WI. Diffusional models useful in biopharmaceutics-drug release rate processes. Journal of Pharmaceutical Sciences. 1967; 56(3): 315- 324.
30. Peppas NA, Ritger PL. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. Journal of Control Release. 1987; 5(1): 37-42.
31. Use of International Standard ISO 10993-1. Biological evaluation of medical devices- Part 1: Evaluation and testing within a risk management process, 2016
43 Views | 9 Downloads
How to Cite
Kaundal N, Kumar P. Formulation and Evaluation of Ethosomal Cream containing Resveratrol for the Treatment of Contact Dermatitis. JDDT [Internet]. 15May2024 [cited 17May2024];14(5):49-3. Available from: